These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 15539456

  • 1. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis.
    Elhofy A, Wang J, Tani M, Fife BT, Kennedy KJ, Bennett J, Huang D, Ransohoff RM, Karpus WJ.
    J Leukoc Biol; 2005 Feb; 77(2):229-37. PubMed ID: 15539456
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
    Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD.
    J Immunol; 1995 Nov 15; 155(10):5003-10. PubMed ID: 7594507
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S, Griguoli M, Rosicarelli B, Magliozzi R, Ria F, Serafini B, Aloisi F.
    J Neuroimmunol; 2006 Oct 15; 179(1-2):76-86. PubMed ID: 16870269
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.
    Brain; 2012 May 15; 135(Pt 5):1586-605. PubMed ID: 22447120
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
    Fife BT, Paniagua MC, Lukacs NW, Kunkel SL, Karpus WJ.
    J Neurosci Res; 2001 Nov 15; 66(4):705-14. PubMed ID: 11746391
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
    Mohindru M, Kang B, Kim BS.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):127-35. PubMed ID: 15342203
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.
    Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J.
    J Immunol; 2009 May 15; 182(10):5994-6002. PubMed ID: 19414750
    [Abstract] [Full Text] [Related]

  • 16. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
    Hamilton NH, Banyer JL, Hapel AJ, Mahalingam S, Ramsay AJ, Ramshaw IA, Thomson SA.
    Scand J Immunol; 2002 Feb 15; 55(2):171-7. PubMed ID: 11896933
    [Abstract] [Full Text] [Related]

  • 17. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
    Matejuk A, Buenafe AC, Dwyer J, Ito A, Silverman M, Zamora A, Subramanian S, Vandenbark AA, Offner H.
    J Neurosci Res; 2003 Jan 01; 71(1):89-103. PubMed ID: 12478617
    [Abstract] [Full Text] [Related]

  • 18. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H.
    Nat Med; 2003 Mar 01; 9(3):287-93. PubMed ID: 12598893
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.
    Davoust N, Nataf S, Reiman R, Holers MV, Campbell IL, Barnum SR.
    J Immunol; 1999 Dec 15; 163(12):6551-6. PubMed ID: 10586048
    [Abstract] [Full Text] [Related]

  • 20. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
    Han D, Tian Y, Zhang M, Zhou Z, Lu J.
    Gene Ther; 2007 Mar 15; 14(5):383-95. PubMed ID: 17066098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.